Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
40.82-0.18 (-0.44%)
At close: 04:00PM EDT
40.82 0.00 (0.00%)
After hours: 05:30PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.47B
Enterprise Value 6.99B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.23
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 325.41%
S&P500 52-Week Change 324.78%
52 Week High 343.59
52 Week Low 319.59
50-Day Moving Average 342.11
200-Day Moving Average 334.49

Share Statistics

Avg Vol (3 month) 31.15M
Avg Vol (10 day) 31.19M
Shares Outstanding 5182.2M
Implied Shares Outstanding 6182.2M
Float 877.85M
% Held by Insiders 115.27%
% Held by Institutions 185.22%
Shares Short (May 15, 2024) 47.11M
Short Ratio (May 15, 2024) 47.39
Short % of Float (May 15, 2024) 48.18%
Short % of Shares Outstanding (May 15, 2024) 43.90%
Shares Short (prior month Apr 15, 2024) 47.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.79%
Return on Equity (ttm)-92.45%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -484.52M
Net Income Avi to Common (ttm)-460.47M
Diluted EPS (ttm)-2.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)846.29M
Total Cash Per Share (mrq)4.64
Total Debt (mrq)482.3M
Total Debt/Equity (mrq)85.44%
Current Ratio (mrq)10.22
Book Value Per Share (mrq)3.10

Cash Flow Statement

Operating Cash Flow (ttm)-367.05M
Levered Free Cash Flow (ttm)-212.07M